AT8372U3 - Desmopressin umfassende zusammensetzung - Google Patents

Desmopressin umfassende zusammensetzung Download PDF

Info

Publication number
AT8372U3
AT8372U3 AT0020406U AT2042006U AT8372U3 AT 8372 U3 AT8372 U3 AT 8372U3 AT 0020406 U AT0020406 U AT 0020406U AT 2042006 U AT2042006 U AT 2042006U AT 8372 U3 AT8372 U3 AT 8372U3
Authority
AT
Austria
Prior art keywords
desmopressin
comprehensive composition
comprehensive
composition
desmopressin comprehensive
Prior art date
Application number
AT0020406U
Other languages
English (en)
Other versions
AT8372U2 (de
Inventor
Lars-Erik Olsson
Anders Nilsson
Christina Aston
Original Assignee
Ferring Int Ct Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36218059&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT8372(U3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Int Ct Sa filed Critical Ferring Int Ct Sa
Priority to AT0024906U priority Critical patent/AT8429U3/de
Publication of AT8372U2 publication Critical patent/AT8372U2/de
Publication of AT8372U3 publication Critical patent/AT8372U3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT0020406U 2006-03-02 2006-03-16 Desmopressin umfassende zusammensetzung AT8372U3 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT0024906U AT8429U3 (de) 2006-03-02 2006-03-31 Herstellung einer desmopressin umfassenden zusammensetzung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0600482A SE528446C2 (sv) 2006-03-02 2006-03-02 Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse

Publications (2)

Publication Number Publication Date
AT8372U2 AT8372U2 (de) 2006-07-15
AT8372U3 true AT8372U3 (de) 2007-03-15

Family

ID=36218059

Family Applications (3)

Application Number Title Priority Date Filing Date
AT06005326T ATE394095T1 (de) 2006-03-02 2006-03-15 Stabile desmopressinformulierung in fester form
AT0020406U AT8372U3 (de) 2006-03-02 2006-03-16 Desmopressin umfassende zusammensetzung
AT0043906A AT503320A1 (de) 2006-03-02 2006-03-16 Desmopressin umfassende zusammensetzung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT06005326T ATE394095T1 (de) 2006-03-02 2006-03-15 Stabile desmopressinformulierung in fester form

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT0043906A AT503320A1 (de) 2006-03-02 2006-03-16 Desmopressin umfassende zusammensetzung

Country Status (16)

Country Link
US (1) US20100273709A1 (de)
EP (1) EP1829532B1 (de)
JP (1) JP4976428B2 (de)
AT (3) ATE394095T1 (de)
CY (1) CY1108231T1 (de)
DE (2) DE602006001103D1 (de)
DK (1) DK1829532T3 (de)
ES (1) ES2304033T3 (de)
IL (1) IL193250A0 (de)
NL (1) NL1031397C2 (de)
NO (1) NO20083555L (de)
PL (1) PL1829532T3 (de)
PT (1) PT1829532E (de)
RU (1) RU2340351C1 (de)
SE (1) SE528446C2 (de)
SI (1) SI1829532T1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
ES2260563T3 (es) * 2003-11-13 2006-11-01 Ferring B.V. Paquete de blister y forma farmaceutica solida para ello.
CN103304639A (zh) * 2013-06-08 2013-09-18 深圳翰宇药业股份有限公司 一种纯化去氨加压素中间体的方法
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744239B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4285858A (en) * 1979-10-30 1981-08-25 Mt. Sinai School Of Medicine Of The City University Of N.Y. Vasopressin analogs
US4263283A (en) * 1980-05-16 1981-04-21 Ferring Pharmaceuticals, Inc. Method for prophylaxis and/or treatment of sickle cell disease
SE8306367L (sv) * 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4863737A (en) * 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US6746678B1 (en) * 1991-02-22 2004-06-08 Howard K. Shapiro Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
US7074871B2 (en) * 1992-05-29 2006-07-11 Basell Poliolefine Italia S.R.L. Crystalline polymers of propylene having improved processability in the molten state and process for their preparation
SE9300937L (sv) * 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
SE501677C2 (sv) * 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
HU221617B1 (hu) * 1993-06-29 2002-12-28 Ferring B.V. Vizes készítmény dezmopresszin nazális adagolására
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5985835A (en) * 1993-12-23 1999-11-16 Ferring B.V. Desmopressin for nocturia, incontinence and enuresis
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
WO1995001368A1 (en) * 1993-06-29 1995-01-12 Ferring B.V. Improved synthesis of cyclic peptides
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
US5849322A (en) * 1995-10-23 1998-12-15 Theratech, Inc. Compositions and methods for buccal delivery of pharmaceutical agents
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
SE9604341D0 (sv) * 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US20060025387A1 (en) * 1998-12-23 2006-02-02 Cytoscan Sciences Llc Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
AR014640A1 (es) * 1999-02-23 2001-03-28 Univ Nac Quilmes UNA COMPOSICíoN FARMACÉUTICA INHIBIDORA DE LA DISEMINACIoN METASTÁSICA DURANTE LA CIRUGíA DE UN TUMOR CANCEROSO, UN PROCEDIMENTO DE PREPARACIoN Y UN KIT PARA UNA FORMULACIoN INYECTABLE.
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7060708B2 (en) * 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
GB2355454A (en) * 1999-10-20 2001-04-25 Ferring Bv Antidiuretic agents
AT409081B (de) * 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
GB0015601D0 (en) * 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
US6348486B1 (en) * 2000-10-17 2002-02-19 American Home Products Corporation Methods for modulating bladder function
US6509040B1 (en) * 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
US6667277B2 (en) * 2001-08-24 2003-12-23 National Starch And Chemical Investment Holding Corporation Water dispersible starch based physical form modification of agricultural agents
WO2003094886A2 (en) * 2002-05-07 2003-11-20 Ferring Bv Desmopressin in an orodispersible dosage form
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US20060193825A1 (en) * 2003-04-29 2006-08-31 Praecis Phamaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US7094545B2 (en) * 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
CN1826099B (zh) * 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
US7022340B2 (en) * 2003-07-25 2006-04-04 Ferring B.V. Pharmaceutical composition as solid dosage form and method for manufacturing thereof
EP2322195A2 (de) * 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmazeutische Zusammensetzungen mit niedrigen Dosen von Desmopressin
ES2260563T3 (es) * 2003-11-13 2006-11-01 Ferring B.V. Paquete de blister y forma farmaceutica solida para ello.
US7344725B2 (en) * 2003-11-25 2008-03-18 Alcon, Inc. Use of inorganic nanoparticles to stabilize hydrogen peroxide solutions
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
SI1550439T1 (sl) * 2003-12-29 2006-08-31 Ferring Bv Postopek za pripravo trdne dozirne oblike dezmopresina
BRPI0610046A2 (pt) * 2005-04-22 2010-05-25 Wyeth Corp derivados de benzodioxano e benzodioxolano e usos destes

Also Published As

Publication number Publication date
CY1108231T1 (el) 2014-02-12
NO20083555L (no) 2008-08-18
US20100273709A1 (en) 2010-10-28
AT503320A1 (de) 2007-09-15
PL1829532T3 (pl) 2008-09-30
JP2009528312A (ja) 2009-08-06
DE602006001103D1 (de) 2008-06-19
EP1829532A1 (de) 2007-09-05
SE0600482L (sv) 2006-11-14
DK1829532T3 (da) 2008-08-04
EP1829532B1 (de) 2008-05-07
IL193250A0 (en) 2011-08-01
ES2304033T3 (es) 2008-09-01
RU2007107368A (ru) 2008-09-10
SI1829532T1 (sl) 2008-08-31
DE202006004746U1 (de) 2006-06-29
ATE394095T1 (de) 2008-05-15
NL1031397C2 (nl) 2006-09-18
RU2340351C1 (ru) 2008-12-10
AT8372U2 (de) 2006-07-15
JP4976428B2 (ja) 2012-07-18
PT1829532E (pt) 2009-02-13
NL1031397A1 (nl) 2006-05-08
SE528446C2 (sv) 2006-11-14

Similar Documents

Publication Publication Date Title
FIC20220006I1 (fi) Tafasitamabi
NO2018021I1 (no) sonidegib
BRPI0716325A2 (pt) Composição antimicrobianas
FR2899479B1 (fr) Composition cicatrisante
DE602006019782D1 (de) Kapselperforationsmodul
DE602007002544D1 (de) Nuancierungsmittel
DE602007003893D1 (de) Kippambossanordnung
BRPI0813775A2 (pt) Composição
DE602007000258D1 (de) Kassetteneinspannmechanismus
DE602006020192D1 (de) Riemenscheibenanorndung
ATE528048T1 (de) Schweisshemmende/desodorierende zusammensetzung
DE602007001280D1 (de) Getränkeextraktor
DE602006019150D1 (de) Riemenscheibenanorndung
DE502007000218D1 (de) nsetzungen
DE502007002453D1 (de) Kunstoffverdichtergehäuse
BRPI0810557A2 (pt) composição
DE602007000501D1 (de) Breitbandrichtkoppler
BRPI0811274A2 (pt) Composição
BRPI0716458A2 (pt) Composição de vulcanizado
DE602006016174D1 (de) Blisterverpackungsverfahren
DE502007001629D1 (de) Rfahren
DE502007000361D1 (de) Stanznieteinheit
DE602007000333D1 (de) Napfbefestigungsvorrichtung
BRPI0811002A2 (pt) Composição biofertilizante
AT8372U3 (de) Desmopressin umfassende zusammensetzung

Legal Events

Date Code Title Description
HA9K Mention of the inventor

Inventor name: OLSSON LARS-ERIK, MALMOE (SE); NILSSON ANDERS, LUND

MA9K Ceased due to renunciation

Effective date: 20071023